[go: up one dir, main page]

ITRM20050169A1 - Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento. - Google Patents

Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento.

Info

Publication number
ITRM20050169A1
ITRM20050169A1 IT000169A ITRM20050169A ITRM20050169A1 IT RM20050169 A1 ITRM20050169 A1 IT RM20050169A1 IT 000169 A IT000169 A IT 000169A IT RM20050169 A ITRM20050169 A IT RM20050169A IT RM20050169 A1 ITRM20050169 A1 IT RM20050169A1
Authority
IT
Italy
Prior art keywords
medicines
characterization
genes
model system
control aging
Prior art date
Application number
IT000169A
Other languages
English (en)
Italian (it)
Inventor
Alessandro Cellerino
Original Assignee
Lay Line Genomics Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lay Line Genomics Spa filed Critical Lay Line Genomics Spa
Priority to IT000169A priority Critical patent/ITRM20050169A1/it
Priority to EP05823575A priority patent/EP1871427A2/fr
Priority to PCT/IT2005/000753 priority patent/WO2006106544A2/fr
Priority to PCT/IT2006/000238 priority patent/WO2006106558A2/fr
Publication of ITRM20050169A1 publication Critical patent/ITRM20050169A1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/0004Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0008Screening agents using (non-human) animal models or transgenic animal models or chimeric hosts, e.g. Alzheimer disease animal model, transgenic model for heart failure
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT000169A 2005-04-07 2005-04-07 Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento. ITRM20050169A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT000169A ITRM20050169A1 (it) 2005-04-07 2005-04-07 Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento.
EP05823575A EP1871427A2 (fr) 2005-04-07 2005-12-22 Utilisation de nothobranchius furzeri en tant que systeme de modele pour la caracterisation de medicaments qui regulent le vieillissement
PCT/IT2005/000753 WO2006106544A2 (fr) 2005-04-07 2005-12-22 Utilisation de nothobranchius furzeri en tant que systeme de modele pour la caracterisation de medicaments qui regulent le vieillissement
PCT/IT2006/000238 WO2006106558A2 (fr) 2005-04-07 2006-04-07 Utilisation de nothobranchius furzeri comme systeme de modele pour la caracterisation des genes du vieillissement

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000169A ITRM20050169A1 (it) 2005-04-07 2005-04-07 Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento.

Publications (1)

Publication Number Publication Date
ITRM20050169A1 true ITRM20050169A1 (it) 2006-10-08

Family

ID=36579492

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000169A ITRM20050169A1 (it) 2005-04-07 2005-04-07 Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento.

Country Status (3)

Country Link
EP (1) EP1871427A2 (fr)
IT (1) ITRM20050169A1 (fr)
WO (2) WO2006106544A2 (fr)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH692837A5 (it) * 1997-07-02 2002-11-29 Lisapharma Spa Composizione farmaceutica per uso alimentare, dietetico o medicinale adatta a migliorare l'assorbimento orale dei polifenoli e particolarmente del resveratrolo presenti nell'uva e nei suoi p
DE69925362T2 (de) * 1998-02-23 2006-01-19 Phylonix Pharmaceuticals Inc., Cambridge Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
EP1335645A2 (fr) * 2000-07-31 2003-08-20 Regents Of The University Of Minnesota Inhibition de l'expression genique au moyen d'analogues de polynucleotides
US20020039725A1 (en) * 2000-08-17 2002-04-04 Shedd Tommy R. Fish hatching method and apparatus
US6943025B2 (en) * 2001-01-10 2005-09-13 Children's Medical Center Corporation Method for identifying genes involved in cell proliferation
US20020174447A1 (en) * 2001-01-23 2002-11-21 Greenspan Ralph J. Method for functional mapping of an alzheimer's disease gene network and for identifying therapeutic agents for the treatment of alzheimer's disease
WO2003052106A1 (fr) * 2001-12-17 2003-06-26 Children's Medical Center Corporation Procede de criblage de composes
CA2500967A1 (fr) * 2002-09-11 2004-03-25 Dana-Farber Cancer Institute Modelisation du cancer a l'aide de poissons transgeniques
GB0301977D0 (en) * 2003-01-28 2003-02-26 Daniolabs Ltd Method for creating a model amenable to high-throughput screening
AU2003901269A0 (en) * 2003-03-19 2003-04-03 Victor Chang Cardiac Research Institute Limited Model for muscular dystrophy
NZ549354A (en) * 2004-02-03 2009-10-30 Hybrid Biosciences Pty Ltd Method of identifying genes which promote hybrid vigour and hybrid debility and uses thereof
WO2005098428A2 (fr) * 2004-04-07 2005-10-20 Marinus Pharmaceuticals, Inc. Procede et systeme de criblage de composes pour leur activite musculaire et/ou neurologique chez des animaux
GB2413847A (en) * 2004-04-26 2005-11-09 Daniolabs Ltd Bone disease models

Also Published As

Publication number Publication date
WO2006106544A3 (fr) 2007-05-18
WO2006106558A3 (fr) 2007-03-15
EP1871427A2 (fr) 2008-01-02
WO2006106558A2 (fr) 2006-10-12
WO2006106544A2 (fr) 2006-10-12

Similar Documents

Publication Publication Date Title
ITRM20040362A1 (it) Sistema per la realizzazione di costruzioni complesse.
EP2037737A4 (fr) Protéines, acides nucléiques encodant celles-ci et leurs procédés d'utilisation associés
DE602004016054D1 (de) Brennstoffzellensystem
EP1824971A4 (fr) Genes clostridiaux genetiquement modifies, proteines codees par ces genes modifies et utilisations de ceux-ci
DE502004011730D1 (de) Brennstoffzellensystem
DE602005027567D1 (de) 1-aza-bicycloä3.3.1ünonane
ITMO20030134A1 (it) Sistema di pesatura
DE602004004068D1 (de) Speichersteuerungssystem
FI20041642A0 (fi) Jarrukatkoja
EP1908480A4 (fr) Regulateur d'interferon- alpha
FI20045252L (fi) AV-järjestelmä sekä ohjain
ITRM20050169A1 (it) Uso di nothobranchius furzeri come sistema modello per la caratterizzazione di geni e farmaci che controllano l'invecchiamento.
DE112004002487D2 (de) Brennstoffzellensystem
ITRM20030283A0 (it) Mezzi terapeutici e diagnostici per i papillomi.
ITMI20031075A1 (it) Sistema per il comando di sblocco negli schienali
ITVE20040039A1 (it) Complesso di elementi modulari per la realizzazione di mobili componibili.
ITMI20021774A1 (it) Sistema per realizzare materassi personalizzati.
ITRM20030440A0 (it) Sistema d'indicazione temporale, in particolare dell'orario.
ITMC20030116A1 (it) "sistema di corde salvavita"
ITRM20040003A1 (it) Sistema modulare, in particolare per la realizzazione di strutture espositive.
FI20040257A0 (fi) Parannus puoliperävaunujärjestelmässä
FR2881050B1 (fr) Dcchol chez les nouveaux-nes
FI20030825A0 (fi) Parvijärjestelmä
ITMI20051624A1 (it) Sistema di controllo dell'erogazione di carburanti
ITPD20040024A1 (it) Sistema di connessione rapida, particolarmente per la connessione di elementi di strutture espositive